Monte Rosa Therapeutics, Inc. (GLUE) reported Q1 Revenue
Tweet
Share
E-mailGet Alerts GLUE Hot Sheet
Join SI Premium – FREE
Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) reported Q1 Revenue for the quarter came in at $84.93 million versus the consensus estimate of $4.91 million.
For earnings history and earnings-related data on Monte Rosa Therapeutics, Inc. (GLUE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Amber Enterprises India Ltd (AMBER:IN) to Overweight
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
- ICICI Securities Downgrades Manappuram Finance Ltd (MGFL:IN) to Hold (3)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
